Canada markets closed

Glenmark Pharmaceuticals Limited (GLENMARK.BO)

BSE - BSE Real Time Price. Currency in INR
Add to watchlist
1,265.70+35.05 (+2.85%)
At close: 03:33PM IST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2024-03-31
2023-03-31
2022-03-31
2021-03-31
Cash flows from operating activities
Net Income
-15,016,680
-15,016,680
2,972,450
9,417,110
9,700,380
Depreciation & amortization
4,495,610
6,308,100
6,112,680
4,867,150
4,435,540
Stock based compensation
36,280
49,620
67,740
79,160
79,390
Change in working capital
-2,451,240
-7,969,530
-10,744,810
-5,612,610
-3,858,380
Inventory
-149,820
-5,138,580
-3,751,690
-2,034,190
-1,338,080
Other working capital
3,945,440
-11,638,220
176,290
3,185,350
3,564,550
Other non-cash items
3,020,280
14,010,900
10,926,710
4,670,440
3,059,210
Net cash provided by operating activites
12,296,170
-2,654,440
6,253,920
11,086,520
11,312,130
Cash flows from investing activities
Investments in property, plant and equipment
-8,350,730
-8,983,780
-6,077,630
-7,901,170
-7,747,580
Purchases of investments
0
0
-60,080
-400,180
0
Sales/Maturities of investments
70,510
70,510
50,000
300,000
0
Other investing activites
-888,370
-166,320
-670
4,556,030
-29,080
Net cash used for investing activites
-7,376,570
45,608,930
-5,284,910
-3,332,800
-6,752,360
Net change in cash
-290,570
3,893,220
194,450
2,548,810
283,960
Cash at beginning of period
9,163,510
14,430,260
14,105,260
11,380,950
11,102,750
Cash at end of period
7,806,490
16,582,700
14,430,260
14,105,260
11,380,950
Free Cash Flow
Operating Cash Flow
12,296,170
-2,654,440
6,253,920
11,086,520
11,312,130
Capital Expenditure
-8,350,730
-8,983,780
-6,077,630
-7,901,170
-7,747,580
Free Cash Flow
3,945,440
-11,638,220
176,290
3,185,350
3,564,550